Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
This observational study aims to explore multimodal phenotyping in adolescents hospitalized with depression and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: The PEDAL Intervention - Reducing Affective Lability in Bipolar Disorder [Phase 2]
Phase 2 clinical trial evaluating the PEDAL Intervention to reduce affective lability in bipolar disorder; recruitment status is NOT_YET_REC…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: HD-tDCS for Adolescent Bipolar Depression Targeting S1 [NA]
A clinical trial evaluating high-definition transcranial direct current stimulation targeting the primary somatosensory cortex for adolescen…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders [NA]
A completed clinical trial assessing immersive virtual reality–based cognitive remediation for mood- and psychosis-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Acute Alcohol Response In Bipolar Disorder: a fMRI Study [NA]
A completed UT Austin clinical trial examined acute alcohol response in individuals with bipolar disorder using fMRI, with results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder [NA]
A ClinicalTrials.gov entry announces a study evaluating Dialectical Behavior Therapy for youth with bipolar disorder or at familial risk, cu…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder [NA]
Recruitment is ongoing for a pragmatic, patient-oriented extension study of Dialectical Behavior Therapy booster sessions for youth with or …
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3) [NA]
A clinical trial assessing a three-level model of dialectical behavior therapy–informed care for youth with or at familial risk for bipolar …
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Intervention for Comorbid Substance Use and Bipolar Disorders [NA]
The clinical trial evaluating an intervention for comorbid bipolar disorder and substance use disorders has completed.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness [NA]
A VA-sponsored clinical trial is evaluating an exercise-based rehabilitation program for veterans with schizophrenia, schizoaffective disord…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Visual Perception in Schizophrenia [NA]
A University of Rochester trial is currently recruiting to study visual perception in schizophrenia and related disorders.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation [NA]
The trial evaluating causal lesion network-guided transcranial electrical stimulation for bipolar mania has completed. Results have been pos…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder [NA]
This clinical trial update reports on ketogenic and nutritional interventions for first-episode Bipolar I Disorder and related psychotic con…
-
FDA approval · 2025-11-04FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for RISPERIDONE from Amneal Pharmaceuticals LLC under an ANDA, authorizing a new or updated generic …
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression [Phase 3]
Phase 3 trial evaluating ITI-007 (lumateperone) as monotherapy for bipolar depression has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder [Phase 3]
Open-label, flexible-dose study to evaluate the long-term safety and tolerability of cariprazine in pediatric participants with schizophreni…
-
FDA approval · 2025-10-23FDA Approved: OLANZAPINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for olanzapine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder [Phase 2]
A Phase 2 clinical trial investigating circadian rhythm correction as a treatment approach for bipolar disorder and delayed sleep-wake phase…
-
FDA label_change · 2025-10-23FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for olanzapine from Aurobindo Pharma Limited. This action typically involves labeling changes for th…
-
FDA approval · 2025-10-22FDA Approved: ARIPIPRAZOLE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the original application for aripiprazole from Quagen Pharmaceuticals LLC, marking the availability of a generic aripiprazole p…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders [NA]
This entry notes the completion of a VA Office of Research and Development–sponsored clinical trial evaluating post-hospital interventions f…
-
CLINICAL_TRIALS safety_alert · 2025-10-21Clinical Trial Update: Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
An observational safety study evaluating ADASUVE (loxapine inhalation powder) for agitation associated with schizophrenia or Bipolar I disor…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Mobile Self-Tracking of Mental Health [NA]
This clinical trial update notes the completion and posting of results for a mobile self-tracking study addressing mental health conditions …
-
FDA label_change · 2025-10-10FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal ODT (lamotrigine) from GlaxoSmithKline, likely updating labeling to reflect the orally …
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
This clinical trial update describes an ongoing study assessing attentional biases, reward sensitivity, and cognitive control in adults with…